| Bickert's Orthotics And Prosthetics | |
| 2106 S. Tate St, Corinth, Mississippi 38834 | |
| (662) 415-7445 |
| Name | Bickert's Orthotics And Prosthetics |
|---|---|
| Organization Name | Bickerts Orthotics & Prosthetics |
| Location | 2106 S. Tate St, Corinth, Mississippi 38834 |
| Type | Prosthetic/Orthotic Supplier |
| Phone | (662) 415-7445 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
GenSpera, Inc. announced that the first patient was dosed in the ongoing Phase I clinical study of its chemotherapeutic agent, G-202, at the Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio in San Antonio, Texas.
MedeAnalytics, a leading provider of healthcare performance management solutions, today announced the launch of its Patient Access Resource Center. Created in response to growing interest in the front end of the revenue cycle, the resource center provides educational information on top key performance indicators and industry trends, as well as best-practice tools and links to leading resources.
Researchers in the United States say one of the reasons why many patients do not do well after blood transfusions is because donated blood rapidly loses some of its life-saving properties.
For those infected with the 2009 pandemic influenza A (H1N1) virus, extreme obesity was a powerful risk factor for death, according to an analysis of a public health surveillance database. In a study to be published in the February 1, 2011, issue of Clinical Infectious Diseases, researchers associated extreme obesity with a nearly three-fold increased odds of death from 2009 H1N1 influenza. Half of Californians greater than 20 years of age hospitalized with 2009 H1N1 were obese.
Brookstone Pharmaceuticals, an emerging specialty pharmaceutical company, announced today its decision to change the name of the company to Acella Pharmaceuticals, LLC. This decision has been made to create a company image and brand that more accurately mirrors our commitment to "Accelerating the Health Care Solution" by bringing quality affordable products to customers and patients. Mark Pugh, CEO states, "As we have grown over the last few years, we have evolved into a more integrated pharmaceutical company.
› Verified 3 days ago
| NPI Number | 1386082030 |
| Organization Name | BICKERTS ORTHOTICS & PROSTHETICS |
| Type | Prosthetic/Orthotic Supplier |
| Address | 2106 S Tate St, Corinth, MS 38834 |
| Phone Number | 662-795-4555 |
News Archive
GenSpera, Inc. announced that the first patient was dosed in the ongoing Phase I clinical study of its chemotherapeutic agent, G-202, at the Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio in San Antonio, Texas.
MedeAnalytics, a leading provider of healthcare performance management solutions, today announced the launch of its Patient Access Resource Center. Created in response to growing interest in the front end of the revenue cycle, the resource center provides educational information on top key performance indicators and industry trends, as well as best-practice tools and links to leading resources.
Researchers in the United States say one of the reasons why many patients do not do well after blood transfusions is because donated blood rapidly loses some of its life-saving properties.
For those infected with the 2009 pandemic influenza A (H1N1) virus, extreme obesity was a powerful risk factor for death, according to an analysis of a public health surveillance database. In a study to be published in the February 1, 2011, issue of Clinical Infectious Diseases, researchers associated extreme obesity with a nearly three-fold increased odds of death from 2009 H1N1 influenza. Half of Californians greater than 20 years of age hospitalized with 2009 H1N1 were obese.
Brookstone Pharmaceuticals, an emerging specialty pharmaceutical company, announced today its decision to change the name of the company to Acella Pharmaceuticals, LLC. This decision has been made to create a company image and brand that more accurately mirrors our commitment to "Accelerating the Health Care Solution" by bringing quality affordable products to customers and patients. Mark Pugh, CEO states, "As we have grown over the last few years, we have evolved into a more integrated pharmaceutical company.
› Verified 3 days ago
News Archive
GenSpera, Inc. announced that the first patient was dosed in the ongoing Phase I clinical study of its chemotherapeutic agent, G-202, at the Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio in San Antonio, Texas.
MedeAnalytics, a leading provider of healthcare performance management solutions, today announced the launch of its Patient Access Resource Center. Created in response to growing interest in the front end of the revenue cycle, the resource center provides educational information on top key performance indicators and industry trends, as well as best-practice tools and links to leading resources.
Researchers in the United States say one of the reasons why many patients do not do well after blood transfusions is because donated blood rapidly loses some of its life-saving properties.
For those infected with the 2009 pandemic influenza A (H1N1) virus, extreme obesity was a powerful risk factor for death, according to an analysis of a public health surveillance database. In a study to be published in the February 1, 2011, issue of Clinical Infectious Diseases, researchers associated extreme obesity with a nearly three-fold increased odds of death from 2009 H1N1 influenza. Half of Californians greater than 20 years of age hospitalized with 2009 H1N1 were obese.
Brookstone Pharmaceuticals, an emerging specialty pharmaceutical company, announced today its decision to change the name of the company to Acella Pharmaceuticals, LLC. This decision has been made to create a company image and brand that more accurately mirrors our commitment to "Accelerating the Health Care Solution" by bringing quality affordable products to customers and patients. Mark Pugh, CEO states, "As we have grown over the last few years, we have evolved into a more integrated pharmaceutical company.
› Verified 3 days ago
Walgreens #1913 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2026 Highway 72 E, Corinth, Mississippi 38834 Phone: (662) 287-4066 | |
Kroger Pharmacy #25-454 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 104 Highway 72 W, Corinth, Mississippi 38834 Phone: (662) 287-8304 | |
Walmart Pharmacy 10-0105 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2301 S Harper Rd, Corinth, Mississippi 38834 Phone: (662) 286-1051 | |
Gunn Drug Co Type: Long Term Care Pharmacy Location: 1815 E Shiloh Rd, Corinth, Mississippi 38834 Phone: (662) 287-8062 | |
Med Supply Plus-corinth Type: Durable Medical Equipment & Medical Supplies Supplier Location: 507 S Fulton Dr, Corinth, Mississippi 38834 Phone: (662) 286-8222 |